Influence of estrogen metabolism on proliferation of human breast cancer

[1]  M. Osborne,et al.  Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells , 1993, Breast Cancer Research and Treatment.

[2]  M. Osborne,et al.  Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. , 1993, Journal of the National Cancer Institute.

[3]  J. Seegers,et al.  Effects of 17β-Estradiol Metabolites on Cell Cycle Events in MCF-7 Cells , 1992 .

[4]  M. Osborne,et al.  Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. , 1992, Journal of the National Cancer Institute.

[5]  J. Heidel,et al.  Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer , 1992, Cancer.

[6]  H. Bradlow,et al.  Influence of indole-3-carbinol on the hepatic microsomal formation of catechol estrogens , 1991, Steroids.

[7]  J. Liehr,et al.  Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. , 1991, Cancer research.

[8]  Michnovicz Jj,et al.  Altered estrogen metabolism and excretion in humans following consumption of indole‐3‐carbinol , 1991 .

[9]  H. Bradlow,et al.  Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture , 1990, Steroids.

[10]  H. Bradlow,et al.  Induction of estradiol metabolism by dietary indole-3-carbinol in humans. , 1990, Journal of the National Cancer Institute.

[11]  J. Seegers,et al.  The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. , 1989, Journal of steroid biochemistry.

[12]  T. Utsumi.  [Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue]. , 1989, Nihon Geka Gakkai zasshi.

[13]  J. Fishman,et al.  Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Blankenstein,et al.  Metabolism of estradiol by human breast cancer. , 1988, European journal of cancer & clinical oncology.

[15]  H. Bradlow,et al.  16α‐Hydroxylation of Estradiol: A Possible Risk Marker for Breast Cancer , 1986 .

[16]  H. Bradlow,et al.  Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Santen,et al.  In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. , 1984, The Journal of clinical endocrinology and metabolism.

[18]  A. Conney,et al.  The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. , 1984, The Journal of clinical endocrinology and metabolism.

[19]  H. Bradlow,et al.  Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. , 1984, The Journal of biological chemistry.

[20]  K. Anderson,et al.  Abnormal oxidative metabolism of estradiol in women with breast cancer. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Paul,et al.  Catecholestrogen synthesis and metabolism by human breast tumors in vitro. , 1979, Cancer Research.

[22]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.